Intravenous Dexmedetomidine as an Adjuvant to Locoregional Anesthesia in Pediatric Surgery: a Prospective, Randomized, Double-blind, Placebo-controlled Study. DEXPED

Status: Recruiting
Location: See location...
Intervention Type: Other, Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

The main objective of this study is to study the impact of intravenous dexmedetomidine combined with locoregional anesthesia on postoperative pain in children undergoing surgery. Secondary objectives was to compare beetwen groups : Post-operative pain; opioid consumption; incidence of emergence delirium, post-operative behavioral disorders, length of stay in the PACU, adverse events , parental satisfaction and quality of life.The goal of this clinical trial is to assess intravenous dexmedetomidine to prevent post-operative pain in children undergoing surgery. This study is prospective and children will be randomized in one of the following arm: * Dexmedetomidine (experimental treatment) * Placebo The experimental treatment or placebo will be administrated at one time point at the time of incision. Participants and their legal representative will have to respond to questionnaires at several time points following the surgery: Day 1, Week 1, Month 3 and Month 6.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Maximum Age: 7
Healthy Volunteers: f
View:

• Age 1 to 7 years old male or female

• To be hospitalized for scheduled urovisceral orchidopexy or peritoneovaginal canal surgery (inguinal hernia or hydrocele cure) on an outpatient basis

• Local-regional anesthesia via Transversus Abdominis Plane (TAP) block and/or pudendal block

• National health insurance coverage

• Have obtained signed informed consent from holders of parental authority

• American Society of Anesthesiology (ASA) score : 1-2

• French read, written and spoken by legal representatives

Locations
Other Locations
France
UH of Montpellier
RECRUITING
Montpellier
Contact Information
Primary
Julien PICO, MD
j-pico@chu-montpellier.fr
+33 7 88 01 44 14
Time Frame
Start Date: 2025-02-03
Estimated Completion Date: 2028-07-03
Participants
Target number of participants: 200
Treatments
Experimental: Dexmedetomidine
Intravenous administration of 1 µg /kg of dexmedetomidine in 10 ml of 0.9% sodium chloride at the time of incision.
Placebo_comparator: Placebo
Intravenous administration of 10 ml sodium chloride 0.9% at the time of incision
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Montpellier

This content was sourced from clinicaltrials.gov